Neha Manpuria
Stock Analyst at Bank of America Securities
(2.67)
# 2,824
Out of 4,468 analysts
20
Total ratings
73.3%
Success rate
5.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Neha Manpuria
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RDY Dr. Reddy's Laboratories | Reiterated: Buy | $19 → $16 | $14.38 | +13.09% | 6 | Jun 18, 2026 | |
| NSE: DRREDDY Dr. Reddy's Laboratories Limited | Reiterated: Buy | ₹1,620 → ₹1,600 | $1,374.10 | +16.44% | 2 | Dec 15, 2025 | |
| NSE: ALKEM Alkem Laboratories Limited | Upgraded: Hold | ₹5,530 | $5,562.50 | -0.58% | 1 | Aug 13, 2025 | |
| NSE: LUPIN Lupin Limited | Upgraded: Hold | ₹1,930 → ₹1,970 | $2,476.00 | -20.44% | 2 | Aug 8, 2025 | |
| NSE: CIPLA Cipla Limited | Maintained: Sell | ₹1,420 → ₹1,500 | $1,458.20 | +2.87% | 2 | Jul 27, 2025 | |
| NSE: AUROPHARMA Aurobindo Pharma Limited | Maintained: Buy | ₹1,350 | $1,620.50 | n/a | 1 | May 27, 2025 | |
| NSE: MANKIND Mankind Pharma Limited | Maintained: Sell | ₹2,150 | $2,528.60 | n/a | 1 | May 21, 2025 | |
| NSE: MAXHEALTH Max Healthcare Institute Limited | Maintained: Hold | ₹1,170 | $1,153.40 | n/a | 1 | May 21, 2025 | |
| NSE: DIVISLAB Divi's Laboratories Limited | Maintained: Buy | ₹7,150 | $6,757.00 | n/a | 1 | May 19, 2025 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Maintained: Buy | ₹8,150 | $8,893.50 | n/a | 1 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,020 | $2,462.30 | n/a | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,940 | $1,904.80 | n/a | 1 | Jan 31, 2025 |
Dr. Reddy's Laboratories
Jun 18, 2026
Reiterated: Buy
Price Target: $19 → $16
Current: $14.38
Upside: +13.09%
Dr. Reddy's Laboratories Limited
Dec 15, 2025
Reiterated: Buy
Price Target: ₹1,620 → ₹1,600
Current: $1,374.10
Upside: +16.44%
Alkem Laboratories Limited
Aug 13, 2025
Upgraded: Hold
Price Target: ₹5,530
Current: $5,562.50
Upside: -0.58%
Lupin Limited
Aug 8, 2025
Upgraded: Hold
Price Target: ₹1,930 → ₹1,970
Current: $2,476.00
Upside: -20.44%
Cipla Limited
Jul 27, 2025
Maintained: Sell
Price Target: ₹1,420 → ₹1,500
Current: $1,458.20
Upside: +2.87%
Aurobindo Pharma Limited
May 27, 2025
Maintained: Buy
Price Target: ₹1,350
Current: $1,620.50
Upside: n/a
Mankind Pharma Limited
May 21, 2025
Maintained: Sell
Price Target: ₹2,150
Current: $2,528.60
Upside: n/a
Max Healthcare Institute Limited
May 21, 2025
Maintained: Hold
Price Target: ₹1,170
Current: $1,153.40
Upside: n/a
Divi's Laboratories Limited
May 19, 2025
Maintained: Buy
Price Target: ₹7,150
Current: $6,757.00
Upside: n/a
Apollo Hospitals Enterprise Limited
Feb 11, 2025
Maintained: Buy
Price Target: ₹8,150
Current: $8,893.50
Upside: n/a
Feb 4, 2025
Maintained: Buy
Price Target: ₹2,020
Current: $2,462.30
Upside: n/a
Jan 31, 2025
Maintained: Hold
Price Target: ₹1,940
Current: $1,904.80
Upside: n/a